Molecular Data Statistics
Share Statistics
Molecular Data has 0
shares outstanding. The number of shares has increased by -91.18%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | -91.18% |
| Shares Change (QoQ) | -93.33% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -2.09 and the forward
PE ratio is null.
Molecular Data's PEG ratio is
-0.05.
| PE Ratio | -2.09 |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| Forward PS | n/a |
| PB Ratio | -24.6 |
| P/FCF Ratio | -2.93 |
| PEG Ratio | -0.05 |
Financial Ratio HistoryEnterprise Valuation
Molecular Data has an Enterprise Value (EV) of 746.83M.
| EV / Sales | 0.1 |
| EV / EBITDA | -3.96 |
| EV / EBIT | -3.19 |
| EV / FCF | -3.19 |
Financial Position
The company has a current ratio of 0.96,
with a Debt / Equity ratio of -2.55.
| Current Ratio | 0.96 |
| Quick Ratio | 0.95 |
| Debt / Equity | -2.55 |
| Debt / EBITDA | -0.38 |
| Debt / FCF | -0.3 |
| Interest Coverage | -30.91 |
Financial Efficiency
Return on Equity is 1174.58% and Return on Invested Capital is -773.93%.
| Return on Equity | 1174.58% |
| Return on Assets | -47.9% |
| Return on Invested Capital | -773.93% |
| Revenue Per Employee | $40,192,656.08 |
| Profits Per Employee | $-1,735,650.79 |
| Employee Count | 189 |
| Asset Turnover | 11.09 |
| Inventory Turnover | 2.7K |
Taxes
| Income Tax | 2.46M |
| Effective Tax Rate | -0.75% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 1.16, so Molecular Data's
price volatility has been higher than the market average.
| Beta | 1.16 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.53 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 37.77 |
| Average Volume (20 Days) | n/a |
Income Statement
In the last 12 months, Molecular Data had revenue of 7.6B
and earned -328.04M
in profits. Earnings per share was -2.62.
| Revenue | 7.6B |
| Gross Profit | -10.2M |
| Operating Income | -331.56M |
| Net Income | -328.04M |
| EBITDA | -188.8M |
| EBIT | -172.09M |
| Earnings Per Share (EPS) | -2.62 |
Full Income StatementBalance Sheet
The company has 11.31M in cash and 71.09M in
debt, giving a net cash position of -59.78M.
| Cash & Cash Equivalents | 11.31M |
| Total Debt | 71.09M |
| Net Cash | -59.78M |
| Retained Earnings | -1.08B |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -234.05M
and capital expenditures -116K, giving a free cash flow of -234.16M.
| Operating Cash Flow | -234.05M |
| Capital Expenditures | -116K |
| Free Cash Flow | -234.16M |
| FCF Per Share | -1.87 |
Full Cash Flow StatementMargins
Gross margin is -0.13%, with operating and profit margins of -4.36% and -4.32%.
| Gross Margin | -0.13% |
| Operating Margin | -4.36% |
| Pretax Margin | -4.29% |
| Profit Margin | -4.32% |
| EBITDA Margin | -2.49% |
| EBIT Margin | -4.36% |
| FCF Margin | -3.08% |
